We previously reported that GSTZ1 is downregulated in HCC, leading to increased accumulation of the carcinogenic metabolite succinylacetone and activation of the NRF2/IGF1R pathways through inactivation of KEAP119. The gene discussed is IGF1R; the disease is hepatocellular carcinoma.